Oscillating Positive Expiratory Pressure Therapy May Be Performed Poorly by Children With Cystic Fibrosis

References

1. 1.↵
   1. Ewart W

   . The treatment of bronchiectasis and of chronic bronchial affections by posture and by respiratory exercises. Lancet 1901;158(4063):70–72.

   OpenUrl
2. 2.↵
   1. dos Santos AP,
   2. Guimarães RC,
   3. de Carvalho EM,
   4. Gastaldi AC

   . Mechanical behaviors of Futter VRP1, Shaker, and Acapella devices. Respir Care 2013;58(2):298–304.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Hess DR

   . Airway clearance: physiology, pharmacology, techniques, and practice. Respir Care 2007;52(10):1392–1396.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Flume PA,
   2. Robinson KA,
   3. O'Sullivan BP,
   4. Finder JD,
   5. Vender RL,
   6. Willey-Courand DB,
   7. et al

   ; Clinical Practice Guidelines for Pulmonary Therapies Committee. Cystic fibrosis pulmonary guidelines: airway clearance therapies. Respir Care 2009;54(4):522–537.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Volsko TA,
   2. DiFiore J,
   3. Chatburn RL

   . Performance comparison of two oscillating positive expiratory pressure devices: Acapella versus Flutter. Respir Care 2003;48(2):124–130.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. McIlwaine PM,
   2. Wong LT,
   3. Peacock D,
   4. Davidson AG

   . Long-term comparative trial of positive expiratory pressure versus oscillating positive expiratory pressure (flutter) physiotherapy in the treatment of cystic fibrosis. J Pediatr 2001;138(6):845–850.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. App EM,
   2. Kieselmann R,
   3. Reinhardt D,
   4. Lindemann H,
   5. Dasgupta B,
   6. King M,
   7. Brand P

   . Sputum rheology changes in cystic fibrosis lung disease following two different types of physiotherapy: flutter vs autogenic drainage. Chest 1998;114(1):171–177.

   OpenUrlCrossRefPubMedWeb of Science
8. 8.↵
   1. Walsh BK,
   2. Hood K,
   3. Merritt G

   . Pediatric airway maintenance and clearance in the acute care setting: How to stay out of trouble. Respir Care 2011;56(9):1424–1440; discussion 1440-1444.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. McIlwaine M,
   2. Van Ginderdeuren F

   . Physiotherapy for people with cystic fibrosis: from infant to adult: International Physiotherapy Group for Cystic Fibrosis 2009. Available at https://www.ecfs.eu/sites/default/files/general-content-files/working-groups/ipg-cf/blue%20booklet%202009%20website%20version%20%2B1.pdf. Accessed October 15, 2018.
10. 10.↵
    1. Bradley JM,
    2. Moran FM,
    3. Elborn JS

    . Evidence for physical therapies (airway clearance and physical training) in cystic fibrosis: an overview of five Cochrane systematic reviews. Respir Med 2006;100(2):191–201.

    OpenUrlCrossRefPubMedWeb of Science
11. 11.↵
    1. Hess DR,
    2. Macintyre NR,
    3. Mishoe SC,
    4. Galvin WF

    . Respir Care: principles and practice. 3rd edition. Burlington: Jones and Bartlett; 2015.
12. 12.↵
    1. Hristara-Papadopoulou A,
    2. Tsanakas J,
    3. Diomou G,
    4. Papadopoulou O

    . Current devices of respiratory physiotherapy. Hippokratia 2008;12(4):211–220.

    OpenUrlPubMedWeb of Science
13. 13.↵
    1. Mestriner RG,
    2. Fernandes RO,
    3. Steffen LC,
    4. Donadio MV

    . Optimum design parameters for a therapist-constructed positive-expiratory-pressure therapy bottle device. Respir Care 2009;54(4):504–508.

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    1. Suggett JA,
    2. Meyer A,
    3. Costella S,
    4. Morton R,
    5. Mitchell J

    . Assessment of oscillating positive expiratory pressure devices by means of adult expiratory waveforms: A laboratory study (abstract). Am J Respir Crit Care Med 2014;189:A3036. Available at https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A3036. Accessed October 15, 2018.

    OpenUrl
15. 15.↵
    1. Frownfelter D,
    2. Dean E

    . Cardiovascular and pulmonary physical therapy-E-Book: evidence to practice. London: Elsevier Health Sciences; 2014.
16. 16.↵
    1. Hyatt RE,
    2. Schilder DP,
    3. Fry DL

    . Relationship between maximum expiratory flow and degree of lung inflation. J Appl Physiol 1958;13(3):331–336.

    OpenUrlPubMedWeb of Science
17. 17.↵
    1. Mead J

    . Expiratory flow limitation: a physiologist's point of view. Fed Proc 1980;39(10):2771–2775.

    OpenUrlPubMed
18. 18.↵
    1. McNamara JJ,
    2. Castile RG,
    3. Glass GM,
    4. Fredberg JJ

    . Heterogeneous lung emptying during forced expiration. J Appl Physiol 1987;63(4):1648–1657.

    OpenUrlPubMedWeb of Science
19. 19.↵
    1. McNamara JJ,
    2. Castile RG,
    3. Ludwig MS,
    4. Glass GM,
    5. Ingram RH Jr.,
    6. Fredberg JJ

    . Interdependent regional emptying during forced expiration. J Appl Physiol 1994;76(1):356–360.

    OpenUrlPubMedWeb of Science
20. 20.↵
    1. Fagevik Olsén M,
    2. Lannefors L,
    3. Westerdahl E

    . Positive expiratory pressure–Common clinical applications and physiological effects. Respir Med 2015;109(3):297–307.

    OpenUrlPubMed
21. 21.↵
    1. Lapin A

    . Chest physical therapy in cystic fibrosis: a review. Cardiopulm Phys Ther J 1990;1(3):11–13. Available at https://journals.lww.com/cptj/Citation/1990/01030/Chest_Physical_Therapy_in_Cystic_Fibrosis__A.4.aspx. Accessed October 15, 2018.

    OpenUrl
22. 22.↵
    1. Rand S,
    2. Hill L,
    3. Prasad S

    . Physiotherapy in cystic fibrosis: optimising techniques to improve outcomes. Paediatr Respir Rev 2013;14(4):263–269.

    OpenUrlPubMed
23. 23.↵
    1. Linnane B,
    2. Collins L,
    3. Bussmann N,
    4. O'Connell NH,
    5. Dunne CP

    . Medical devices for cystic fibrosis care may be portable reservoirs of potential pathogens. J Hosp Infect 2017;96(4):397–398.

    OpenUrl